This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03756896
Recruitment Status : Active, not recruiting
First Posted : November 28, 2018
Last Update Posted : October 11, 2023
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Ajay Nooka, Emory University

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 12, 2024
Estimated Study Completion Date : August 31, 2024